Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.Exemption number (b)(4)-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Product performance engineering reviewed the incident information; however, there was no reported device malfunction and the product was not returned.A review of the lot history record and complaint history could not be conducted because the part and lot number were not provided.The reported patient effect of thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, electronic instructions for use (eifu), is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.Article titled: "bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the italian multicenter rai registry." (b)(4).
|